Tech Company Financing Transactions

Infinimmune Funding Round

On 12/6/2022, Infinimmune secured $12 million in Seed funding from Playground Global, Axial and Civilization Ventures.

Transaction Overview

Company Name
Infinimmune
Announced On
12/6/2022
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Investors

Playground Global (Lead Investor)

Axial

Civilization Ventures

private investors (Jacob Becraft)

private investors (Joshua Meier)

private investors (Paul Conley)

private investors (Ron Alfa)

Pear VC

Proceeds Purpose
The company intends to use the funds to expand team of talent, develop R&D capabilities, and scale operations.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
www.infinimmune.com
Email Address
[email protected]
Overview
We screen human samples containing B cells, which encode antibodies. We use single cell genomics to read antibody sequences from single B cells. We write antibodies and create superior drug candidates.
Profile
Infinimmune LinkedIn Company Profile
Social Media
Infinimmune Company Twitter Account
Company News
Infinimmune News
Facebook
Infinimmune on Facebook
YouTube
Infinimmune on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Wyatt McDonnell
  Wyatt McDonnell LinkedIn Profile  Wyatt McDonnell Twitter Account  Wyatt McDonnell News  Wyatt McDonnell on Facebook
Founder
Mike Gibbons
  Mike Gibbons LinkedIn Profile  Mike Gibbons Twitter Account  Mike Gibbons News  Mike Gibbons on Facebook
Founder
Lance Hepler
  Lance Hepler LinkedIn Profile  Lance Hepler Twitter Account  Lance Hepler News  Lance Hepler on Facebook
Founder
David Jaffe
  David Jaffe LinkedIn Profile  David Jaffe Twitter Account  David Jaffe News  David Jaffe on Facebook
Founder
Katie Pfeiffer
  Katie Pfeiffer LinkedIn Profile  Katie Pfeiffer Twitter Account  Katie Pfeiffer News  Katie Pfeiffer on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/6/2022: MALK Organics venture capital transaction
Next: 12/6/2022: Enthea venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.